US Bancorp’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
NMC
OCA
AVM
SB
PAI
SL
6CM
US Bancorp's GOSS Position: Q3 2025 in Review
US Bancorp sold out of Gossamer Bio (GOSS) in Q3 2025, closing a stake of 24,100 shares — an estimated $29.6K sold.
US Bancorp first reported a position in GOSS in Q3 2019 and held it in 16 quarters. The position peaked at $39.1K in Q3 2024. 164 funds tracked by Wall St. Rank hold GOSS as of Q3 2025.
- US Bancorp reported no remaining Gossamer Bio position as of Q3 2025 after selling out during the quarter.
- US Bancorp sold 24,100 Gossamer Bio shares in Q3 2025, an estimated $29.6K.
- US Bancorp first reported a position in Gossamer Bio in Q3 2019 and held it in 16 quarters.
- US Bancorp's Gossamer Bio position peaked at $39.1K in Q3 2024.
- 164 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2025.
Based on US Bancorp's 13F filing for Q3 2025, filed 12 Nov 2025.